Cargando…

PD-1/PD-L1 expression in anal squamous intraepithelial lesions

Introduction: Studies have shown that the PD-1/PD-L1 immunomodulatory pathway slows down anti-tumor immunity in a number of cancers. The description of the expression of these molecules has never been performed in anal low-grade/high grade squamous intra-epithelial lesions (LSIL/HSIL respectively)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bucau, Margot, Gault, Nathalie, Sritharan, Nanthara, Valette, Emy, Charpentier, Charlotte, Walker, Francine, Couvelard, Anne, Abramowitz, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533075/ https://www.ncbi.nlm.nih.gov/pubmed/33062194 http://dx.doi.org/10.18632/oncotarget.27756

Ejemplares similares

Anal Intraepithelial Neoplasia: Precursor of Anal Squamous Cell Carcinoma
por: Sakamoto, Taku, et al.
Publicado: (2022)

Detection of Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma on Colonoscopy
por: Voss, Jordan K., et al.
Publicado: (2022)

Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART
por: Piketty, C, et al.
Publicado: (2010)

Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
por: Wessely, Anja, et al.
Publicado: (2020)

Anal Dysplasia Among Patients With Multiple Human Papillomavirus Anal Lesions: Mosaic or Homogeneity?
por: Lafferre, Emilie, et al.
Publicado: (2021)

The Anal Pap Smear: Cytomorphology of squamous intraepithelial lesions
por: Arain, Shehla, et al.
Publicado: (2005)

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma
por: Chamseddin, Bahir H., et al.
Publicado: (2019)

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
por: Evrard, D., et al.
Publicado: (2020)

Squamous intraepithelial lesions of the anal squamocolumnar junction: Histopathological classification and HPV genotyping
por: Clavero, Omar, et al.
Publicado: (2016)

Abnormal anal cytology risk in women with known genital squamous intraepithelial lesion
por: do Socorro Nobre, Maria, et al.
Publicado: (2016)

Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
por: Albuquerque, A, et al.
Publicado: (2017)

Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma
por: Minoli, Lucia, et al.
Publicado: (2022)

PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
por: Porcellato, Ilaria, et al.
Publicado: (2021)

Endoscopic submucosal dissection for anal intraepithelial neoplasia
por: Miyazaki, Junichi, et al.
Publicado: (2016)

Anal intraepithelial neoplasia: diagnosis, screening, and treatment
por: Siddharthan, Ragavan V., et al.
Publicado: (2019)

Opportunistic detection of anal intraepithelial neoplasia at colonoscopy
por: Forbes, Clara M, et al.
Publicado: (2020)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization
por: Chang, Hyeyoon, et al.
Publicado: (2018)

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance
por: Baas, Marije, et al.
Publicado: (2016)

Current treatment options for management of anal intraepithelial neoplasia
por: Weis, Stephen E
Publicado: (2013)

Anal intraepithelial neoplasia: A review of diagnosis and management
por: Roberts, Joseph R, et al.
Publicado: (2017)

Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
por: Kammerer-Jacquet, Solène-Florence, et al.
Publicado: (2019)

Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males
por: Rovelli, Cristina, et al.
Publicado: (2017)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
por: Ott, P. A., et al.
Publicado: (2017)

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy
por: Chan, Angela MY., et al.
Publicado: (2022)

Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
por: Kim, Hae Su, et al.
Publicado: (2016)

Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions
por: McCloskey, Jenny C., et al.
Publicado: (2017)

Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?
por: Siegenbeek van Heukelom, Matthijs L., et al.
Publicado: (2017)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

PD‐1/PD‐L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta‐analysis focus on PD‐L1 expression level
por: Jin, Zixian, et al.
Publicado: (2023)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

A snapshot of the PD-1/PD-L1 pathway
por: Ghosh, Chinmoy, et al.
Publicado: (2021)

The PD-1:PD-L1 axis in Inflammatory Arthritis
por: Canavan, Mary, et al.
Publicado: (2021)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

PD-1/PD-L1 axis in organ fibrosis
por: Zhao, Youliang, et al.
Publicado: (2023)

Progress of research on PD-1/PD-L1 in leukemia
por: Cao, Huizhen, et al.
Publicado: (2023)

Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis
por: Levy, Dylan A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irlfcbpa9dncflbkfg80j8s7ah